MSI is a key factor in tumorigenesis. It leads to the accumulation of mutations throughout the genome, particularly in genes involved in cell growth regulation and apoptosis. Cancers with high levels of MSI (MSI-H) often exhibit unique histological and clinical features, such as a higher number of tumor-infiltrating lymphocytes and a better response to immunotherapy.
